5,6-benzocoumarin-3-carboxylic acid ethyl ester has been researched along with warfarin in 1 studies
*Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. [MeSH]
*Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beketova, TP; Korolev, VV; Prokhorov, NI; Rumiantsev, GI | 1 |
1 other study(ies) available for 5,6-benzocoumarin-3-carboxylic acid ethyl ester and warfarin
| Article | Year |
|---|---|
[Ultrastructural studies of lung and liver tissue of white rats inhaling 3-phenyl-5,6-benzocoumarin and the ethyl ester of 5,6-benzocoumarin-3-carboxylic acid].
Topics: Animals; Anticoagulants; Coumarins; Dose-Response Relationship, Drug; Environmental Exposure; Liver; Lung; Microscopy, Electron; Rats; Time Factors | 1981 |